Skip to content.Skip to side navigation. Quick Navigation: Skip to content.Skip to side navigation.
GPO Access Home Page.
Jump to selected topic.

advanced
Navigation Bar
About.Help. A-Z Resource List. Locate a Federal Depository Library. Buy Publications. Legislative. Executive. Judicial.
National Archives and Records Administration logo.
Database Features.
•
 Browse
•
 Simple Search
•
 Advanced Search
* Boolean
  * Proximity
• Search History
• Search Tips
•
 Corrections
•

Latest Updates
• User Info
• FAQs
•
 Agency List
•
 Incorporation by Reference
•
 e-CFR Main Page
Related Resources
•
 Code of Federal Regulations
•
 Federal Register
•
 List of CFR
Sections Affected
•
 Regulations.gov
•
 Unified Agenda
•
 All NARA Publications
About Government.
Ben's Guide Logo.
Get Adobe Reader

Home Page > Executive Branch > Code of Federal Regulations > Electronic Code of Federal Regulations

blue pill
e-CFR Data is current as of February 4, 2010

TITLE 21--Food and Drugs

CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES

SUBCHAPTER E--ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS

PART 556--TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD

rule

Subpart A--GENERAL PROVISIONS

§556.1
General considerations; tolerances for residues of new animal drugs in food.
rule

Subpart B--SPECIFIC TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS

§556.20
2-Acetylamino-5-nitrothiazole.
§556.30
Aklomide.
§556.34
Albendazole.
§556.36
Altrenogest.
§556.38
Amoxicillin.
§556.40
Ampicillin.
§556.50
Amprolium.
§556.52
Apramycin.
§556.60
Arsenic.
§556.70
Bacitracin.
§556.90
Buquinolate.
§556.100
Carbadox.
§556.110
Carbomycin.
§556.113
Ceftiofur.
§556.115
Cephapirin.
§556.120
Chlorhexidine.
§556.140
Chlorobutanol.
§556.150
Chlortetracycline.
§556.160
Clopidol.
§556.163
Clorsulon.
§556.165
Cloxacillin.
§556.167
Colistimethate.
§556.169
Danofloxacin.
§556.170
Decoquinate.
§556.180
Dichlorvos.
§556.185
Diclazuril.
§556.200
Dihydrostreptomycin.
§556.220
3,5-Dinitrobenzamide.
§556.225
Doramectin.
§556.226
Enrofloxacin.
§556.227
Eprinomectin.
§556.230
Erythromycin.
§556.240
Estradiol and related esters.
§556.260
Ethopabate.
§556.270
Ethylenediamine.
§556.273
Famphur.
§556.275
Fenbendazole.
§556.277
Fenprostalene.
§556.283
Florfenicol.
§556.286
Flunixin.
§556.290
Furazolidone.
§556.300
Gentamicin sulfate.
§556.304
Gonadotropin.
§556.308
Halofuginone hydrobromide.
§556.310
Haloxon.
§556.320
Hydrocortisone.
§556.330
Hygromycin B.
§556.344
Ivermectin.
§556.346
Laidlomycin.
§556.347
Lasalocid.
§556.350
Levamisole hydrochloride.
§556.360
Lincomycin.
§556.375
Maduramicin ammonium.
§556.380
Melengestrol acetate.
§556.390
Methylparaben.
§556.400
Methylprednisolone.
§556.410
Metoserpate hydrochloride.
§556.420
Monensin.
§556.425
Morantel tartrate.
§556.426
Moxidectin.
§556.428
Narasin.
§556.430
Neomycin.
§556.440
Nequinate.
§556.445
Nicarbazin.
§556.460
Novobiocin.
§556.470
Nystatin.
§556.480
Oleandomycin.
§556.490
Ormetoprim.
§556.495
Oxfendazole.
§556.500
Oxytetracycline.
§556.510
Penicillin.
§556.513
Piperazine.
§556.515
Pirlimycin.
§556.520
Prednisolone.
§556.530
Prednisone.
§556.540
Progesterone.
§556.550
Propylparaben.
§556.560
Pyrantel tartrate.
§556.570
Ractopamine.
§556.580
Robenidine hydrochloride.
§556.590
Salicylic acid.
§556.592
Salinomycin.
§556.597
Semduramicin.
§556.600
Spectinomycin.
§556.610
Streptomycin.
§556.620
Sulfabromomethazine sodium.
§556.625
Sodium sulfachloropyrazine monohydrate.
§556.630
Sulfachlorpyridazine.
§556.640
Sulfadimethoxine.
§556.650
Sulfaethoxypyridazine.
§556.660
Sulfamerazine.
§556.670
Sulfamethazine.
§556.680
Sulfanitran.
§556.685
Sulfaquinoxaline.
§556.690
Sulfathiazole.
§556.700
Sulfomyxin.
§556.710
Testosterone propionate.
§556.720
Tetracycline.
§556.730
Thiabendazole.
§556.735
Tilmicosin.
§556.738
Tiamulin.
§556.739
Trenbolone.
§556.740
Tylosin.
§556.741
Tripelennamine.
§556.745
Tulathromycin.
§556.750
Virginiamycin.
§556.760
Zeranol.
§556.765
Zilpaterol.
§556.770
Zoalene.
rule

For questions or comments regarding e-CFR editorial content, features, or design, email ecfr@nara.gov.

For questions concerning e-CFR programming and delivery issues, email webteam@gpo.gov.

Section 508 / Accessibility